Stock ABVX ABIVAX
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Abivax

Equities

ABVX

FR0012333284

Market Closed - Euronext Paris
Other stock markets
 11:35:25 2024-04-29 am EDT 		After market 11:53:42 am
14.82 EUR 0.00% Intraday chart for Abivax 14.83 +0.07%
04:11pm Abivax: share price rises as two analysts express optimism CF
01:22pm Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target MT

Evolution of the average Target Price on Abivax

Price target over the last 5 years

History of analyst recommendation changes

48028c84143c2677.z7qtPql_tOCNWGIRjmN0KOaTn7tKzbGeW1N30D6fqB0.nfX7RsBO95j8DQ9hx1MFXdCkqtMIndvPLhAYuUroyzD_0NcMnBDB0LQqNw~e00ef23f3ef2d92915a0d2fcc750f394

Analyst Recommendations on Abivax

Abivax: share price rises as two analysts express optimism CF
Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target MT
Guggenheim Starts Abivax With Buy Rating, $50 Price Target MT
Morgan Stanley Adjusts Price Target on Abivax to $16 From $15, Maintains Equalweight Rating MT
Abivax: in green, broker in support CF
ABIVAX : Oddo BHF maintains its outperform rating CF
Valneva: up sharply after positive analysis CF
ABIVAX : Portzamparc downgrades its recommendation CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.82 EUR
Average target price
35.74 EUR
Spread / Average Target
+141.16%
High Price Target
65 EUR
Spread / Highest target
+338.60%
Low Price Target
17.7 EUR
Spread / Lowest Target
+19.43%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Abivax

Morgan Stanley

Ratings for Abivax

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ABVX Stock
  4. Consensus Abivax